Systemic thrombolytic therapy for late-onset portal vein thrombosis after living-donor liver transplantation

Transplantation. 2004 Apr 15;77(7):1014-8.

Abstract

Background: There have been few reports of noninvasive treatment for portal vein thrombosis (PVT) after liver transplantation.

Methods: One adult patient and four pediatric patients developed PVT 5, 14, 14, 16, and 43 months after living-donor liver transplantation, respectively. All five of the patients received a 10-day course of systemic thrombolytic therapy with recombinant tissue plasminogen activator.

Results: After the treatment was completed, successful portal vein recanalization was demonstrated on ultrasonography or multidetector three-dimensional computed tomography angiography in all five cases.

Conclusion: Noninvasive treatment with systemic recombinant tissue plasminogen activator should be considered for selected patients with late-onset PVT after liver transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Liver Transplantation*
  • Living Donors*
  • Male
  • Portal Vein*
  • Recombinant Proteins / therapeutic use
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Venous Thrombosis / drug therapy*

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator